ALIF_B: EBITA margins exceeded 12% in both segments, with strong growth and a positive M&A outlook

About this update from Addlife Ab Class B

Margin and profit improvements drove EBITA above 12% in both segments, with 5% revenue growth and strong cash flow. Acquisition of Edge Medical and a robust M&A pipeline position the group for further growth.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Addlife Ab Class B